4 Hrs
Source:
المشهد
New immunotherapy could avoid bladder removal
An advanced clinical study has demonstrated that a new immunotherapy prevents the need for bladder removal in patients with high-grade bladder cancer. Tendo, the treatment administered instead of surgery, allows patients to preserve their bladder function and results in a complete cancer response in 75% of cases, with those responses lasting for over two years in approximately 60% of patients. Developed by C.G. Oncology, the therapy has successfully prevented cancer recurrence for more than four years in some cases, enhancing patients' quality of life and reducing surgical interventions.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)